ArticleAnnals of translational medicine2022

Immunochemotherapy includes pembrolizumab for stage IIIB lung squamous cell carcinoma: a case report.

Shuliang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.